UCSF

UCSF Neurologist Played Key Role in MS Research Turning to B-Cells, Essential Step to Ocrevus

Dr. Stephen Hauser, chair of the neurology department at the University of California San Francisco, was instrumental in the early research and laterĀ clinical trials that ultimately led toĀ Ocrevus (ocrelizumab), the first therapyĀ approved by the U.S. Food and Drug Administration (FDA)Ā for bothĀ relapsing MSĀ (RMS) and primary progressive multiple sclerosis…

Gladstone Scientist Wins $5.8M NINDS Award for Work in MS and Neurological Diseases

Katerina Akassoglou, PhD, a Gladstone Institutes senior investigator, has been awardedĀ a multiyear, $5.8 millionĀ career grant from the National Institute of Neurological Disorders and Stroke (NINDS) for her work on neurological diseases, including multiple sclerosisĀ (MS). The Gladstone Institutes is a nonprofit community of scientists, affiliated with the…

PCORI Awards $2 Million to Study Treatments for Fatigue in MS Patients

The Patient-Centered Outcomes Research Institute (PCORI) recentlyĀ awarded a sum of $5.5 million to two researchers at the University of California, San FranciscoĀ (UCSF). Bardia Nourbakhsh, MD. (Credit: UCSF) Bardia Nourbakhsh, MD, a clinical fellow in Neurology, receivedĀ aĀ $2 million grant to conduct a randomized, double-blind, placebo-controlled clinical trial to…